SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology trends after reporting H1 revenue up 99% and raising FY2026 guidance to at least $200M, but bulls and bears clash over the widened IFRS losses, stock comp, and dilution risks, with heavy short interest amplifying volatility around the earnings release.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVDA is trending as traders digest a seven-day slide into Wednesday's earnings, with the stock breaking below key technical supports like the 200-day EMA and triggering a frenzied debate on whether the pre-report dip sets up a post-earnings rebound or signals a deeper sell-off. The community is heavily focused on the prospect of another beat-and-raise quarter, tensions over rising memory prices and reported customer price hikes, and a wave of company announcements from the SpaceXAI Vera CPU deal to the Lancium investment and Groq 3 LPX production ramp.

CF Acquisition Corp. VI operates as a blank check company. It focuses on the search of companies in the financial services, healthcare, real estate services, technology and software industries. The company was founded on April 17, 2020 and is headquartered in New York, NY.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

A massive multi-billion-dollar GPU services agreement with an unnamed cloud customer has the community split between those expecting a historic short squeeze and bears warning of looming dilution and financing risks. The debate centers on whether the transformative deal validates Rumble's AI infrastructure pivot or whether the required capital raise and warrants will undermine the stock move.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is surging as the psychedelic sector recalibrates following Eli Lilly's acquisition of ATAI, with traders speculating that a similar buyout premium is now in play for CMPS, especially given its first-mover advantage and impending NDA submission that positions it as the most derisked asset in the space.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The stock is catching attention as a proxy for political volatility, with community debates centering on the administration's trade war with Canada and the new economic sanctions against Iran, fueling both bullish and bearish narratives.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

A sharp price spike on surging volume has AMP trending again, with the community split between bulls citing regulatory tailwinds, European expansion, and payment-sector momentum, and bears dismissing it as another dead-cat bounce for long-suffering holders of a token they label a scam.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Renewed buyout speculation from Betaville is fueling gains, with the community weighing the credibility of the rumor against strong BRIUMVI sales and the upcoming subcutaneous data readout that could boost acquisition value.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

TSLA is under pressure as chatter revolves around the upcoming Cybercab launch event and Nevada's robotaxi approval, with bulls calling the pullback a shakeout while bears point to China recalls and intensifying robotaxi competition.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng's robotics division landed a massive $900M funding round at a $6.3B valuation, but that milestone was overshadowed by a Q2 earnings miss and weak Q3 guidance that cratered the stock to 52-week lows. The community is split between those who see the robotics unit as proof the company is undervalued versus bears who say the core EV business is deteriorating faster than the optionality can offset.

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutus's planned $230M Dutch-auction buyback, funded by its Moderna LNP settlement, is driving intense debate, with retail holders largely refusing the $5-$5.75 range while speculating that retiring 20%+ of the float sets up a squeeze and amplifies future Pfizer/HBV litigation upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CATX https://open.spotify.com/episode/5uMTGQIYlYZuFVSnAOcPUU?si=CSceRvqBQeeVUmoAstpq5w&amp;utm_source=copy-link

Christan

Xander

D. Milne

Joseph Fuller

Tony Karam

Merv

Noble

Listen to this episode from Off Script: A Pharma Manufacturing Podcast on Spotify. Radiopharmaceuticals are a rapidly growing area of oncology, fueled by advances in targeted therapies and expanding product pipelines. But bringing these therapies from development to commercialization presents unique manufacturing challenges, from isotope supply and specialized GMP facilities to the "just-in-time" distribution models required by the short half-lives of these radioactive medicines.